Muscarinic M1, M3, Nicotinic,GABAA and GABAB Receptor ...

Balters E, Francesco M. (2002). New research on epilepsy and behaviour. In Keith. J
Holaway (ed). Nova Publishers, New York, P: 76–89.
Bankier A, Turner M, Hopkins IJ. (1983). Pyridoxine–dependent seizures a wider
clinical spectrum. Arch Dis Child, 58: 415–418.
Barnard EA, Skolnick P, Olsen RW, Moher H, Sieghart W, Biggio G, Braestrup C,
Bateson A, Langer SZ. (1998). International union of pharmacology XV.
Subtypes of γ–Aminobutyric Acid A receptors: classification on the basis of
subunit structure and receptor function. Pharmacol Rev, 50: 291–314
Barnard EA. (2001). The molecular architecture of GABAA receptors Pharmacology
of GABA and glycine neurotransmission. In: Möhler H (eds). Handbook of
Experimental Pharmacology. Berlin, Springer, 150: 94–100.
Bartus RT, Dean RL, Beer B, Lippa AS. (1982). The cholinergic hypothesis of
geriatric memory dysfunction. Science, 217: 408–414.
Bartus RT. (2000). On Neurodegenerative Diseases, Models, and Treatment
Strategies: Lessons Learned and Lessons Forgotten a Generation Following the
Cholinergic Hypothesis. Experimental Neurology, 163: 495–529.
Baumgold J, Fishman PH. (1988). Muscarinic receptor mediated increase in cAMP
levels in SK–N–SH human neuroblastoma cells. Biochem Biophys Res Comm,
154: 1137–1143.
Becker D, Ryan C. (2000). Hypoglycemia: a complication of diabetes therapy in
children. Trends Endocrinol Metab, 11: 198–202.